CAMBRIDGE, Mass.--(BUSINESS WIRE)--Goldfinch Bio, Inc., a biotechnology company focused on developing precision therapies for patients with kidney diseases, today announced that Anthony Johnson, M.D., President and Chief Executive Officer of Goldfinch Bio, will present at the following investor conferences in June:
- The Jefferies 2019 Global Healthcare Conference on Friday, June 7, 2019, at 8:00 a.m. ET in New York, NY.
- The Raymond James Life Sciences & MedTech Conference on Wednesday, June 19, 2019, at 11:30 a.m. ET in New York, NY.
About Goldfinch Bio
Goldfinch Bio is a biotechnology company that is singularly focused on discovering and developing precision therapies for patients with kidney diseases. Just as the goldfinch has long been a symbol of healing and renewal and was a prominent figure of the Renaissance, Goldfinch Bio is leading a new age of therapeutic discovery to transform the treatment paradigm for patients with kidney diseases. Goldfinch was launched in 2016 by Third Rock Ventures, and is headquartered in Cambridge, Mass. For more information, please visit www.goldfinchbio.com.
